Intravenous starches: is suspension the best solution?
| dc.contributor.author | Raghunathan, Karthik | |
| dc.contributor.author | Miller, Timothy E | |
| dc.contributor.author | Shaw, Andrew D | |
| dc.coverage.spatial | United States | |
| dc.date.accessioned | 2017-04-12T21:10:38Z | |
| dc.date.available | 2017-04-12T21:10:38Z | |
| dc.date.issued | 2014-09 | |
| dc.identifier | ||
| dc.identifier | 00000539-201409000-00031 | |
| dc.identifier.eissn | 1526-7598 | |
| dc.identifier.uri | ||
| dc.language | eng | |
| dc.publisher | Ovid Technologies (Wolters Kluwer Health) | |
| dc.relation.ispartof | Anesth Analg | |
| dc.relation.isversionof | 10.1213/ANE.0000000000000186 | |
| dc.subject | Critical Care | |
| dc.subject | Evidence-Based Medicine | |
| dc.subject | Humans | |
| dc.subject | Hydroxyethyl Starch Derivatives | |
| dc.subject | Injections, Intravenous | |
| dc.subject | Isotonic Solutions | |
| dc.subject | Perioperative Care | |
| dc.subject | Plasma Substitutes | |
| dc.subject | Randomized Controlled Trials as Topic | |
| dc.subject | Suspensions | |
| dc.title | Intravenous starches: is suspension the best solution? | |
| dc.type | Journal article | |
| duke.contributor.orcid | Raghunathan, Karthik|0000-0003-2809-5374 | |
| duke.contributor.orcid | Miller, Timothy E|0000-0001-8567-6680 | |
| pubs.author-url | ||
| pubs.begin-page | 731 | |
| pubs.end-page | 736 | |
| pubs.issue | 3 | |
| pubs.organisational-group | Anesthesiology | |
| pubs.organisational-group | Anesthesiology, General, Vascular, High Risk Transplant & Critical Care | |
| pubs.organisational-group | Anesthesiology, VA Anesthesiology Service | |
| pubs.organisational-group | Clinical Science Departments | |
| pubs.organisational-group | Duke | |
| pubs.organisational-group | School of Medicine | |
| pubs.publication-status | Published | |
| pubs.volume | 119 |
Files
Original bundle
- Name:
- HES open mind review. 2014.pdf
- Size:
- 465.63 KB
- Format:
- Adobe Portable Document Format